MOH
- Marketing authorisation holder: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- Status: likely_approved
Anktiva (INBAKICEPT) regulatory status in United Arab Emirates.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it.
ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU holds the UAE marketing authorisation.